fbpx

New online training to support people living with diabetes

Wednesday 6 March 2019

 

JOINT MEDIA RELEASE

 

A new online course to support pharmacists in caring for people living with diabetes has been launched today by the peak national body for all pharmacists, the Pharmaceutical Society of Australia (PSA) and Diabetes Qualified (DQ), the training arm of Diabetes NSW & ACT.

 

The Diabetes in Practice for Pharmacists course aims to help improve pharmacists’ health literacy to better support people living with diabetes to make informed choices about their health and thus improve health outcomes.

 

Diabetes in Practice for Pharmacists also supports several of the national priority actions in the recently released National Diabetes Implementation Strategy, contributing to the strategy’s goal of prioritising Australia’s response to diabetes and its complications and comorbidities, and reducing the impact of diabetes in the community.

 

PSA National President Dr Chris Freeman said the course focused on applying diabetes knowledge in everyday practice and supporting patients through better engagement, asking more meaningful questions and giving advice or referring on as needed.

 

“This new training program supports some of the key actions in PSA’s Pharmacists in 2023 by helping pharmacists in all practice settings have more supportive and meaningful conversations with their patients to prevent medicine misadventure and create better health outcomes,” Dr Freeman said.

 

“Diabetes is explained in simple terms using case studies and real life scenarios to provide examples of appropriate language to answer questions from a person living with diabetes about diabetes management and related products.”

 

Sturt Eastwood, CEO of Diabetes NSW & ACT said, “For many people living with diabetes their pharmacist is the health professional they see the most, so there is ample opportunity to have a conversation about diabetes care. We know that education leads to more effective self-care, which leads to reduced complications and better health outcomes.”

 

The course includes interactive modules and is relevant for pharmacists, intern pharmacists and pharmacy students with a special interest in diabetes. The introductory module is free for PSA members and the course provides pharmacists with the flexibility to work at their own pace.

 

To access individual modules or the full course, please visit the PSA website or DQ website.

 

The PSA and Australian Diabetes Educators Association (ADEA) co-developed Pharmacist Diabetes Educator career pathway also supports pharmacists providing services to people living with diabetes.

 

Media contacts:
PSA: Jarryd Luke, 0487 922 176
DQ: Danilia Walker, 02 9552 9904

Exceptional SA and NT pharmacists honoured

Tuesday 5 March 2019

 

Respected pharmacist Dr Danny Tsai received the SA/NT Pharmacist of the Year Award at the Annual Celebration of Excellence in Pharmacy hosted by the Pharmaceutical Society of Australia (PSA) tonight.

 

Minister for Industry and Skills The Hon David Pisoni MP presented the award to Dr Tsai at Veale Gardens in Adelaide.

 

Veronika Seda won the SA/NT Early Career Pharmacist Development Award, while Karissa Searle was presented with the 2017 PSA Gold Medal and Wala Hamid Haj Ali with the 2018 Gold Medal.

 

PSA SA/NT President Robyn Johns congratulated Dr Tsai and commended his significant contribution to the safe and effective use of medicines in Aboriginal and Torres Strait Islander people and for improving clinical pharmacy services in Central Australia.

 

Dr Tsai is the inaugural Antimicrobial Stewardship pharmacist at the Alice Springs Hospital and his current research interests include investigating the demographics and bacteriology of severe community acquired pneumonia in Central Australia.

 

“Not only is Danny a terrific mentor for early career pharmacists, he also supports student placements in Alice Springs and contributes to ongoing education for health professionals working in remote areas,” said Ms Johns.

 

Ms Seda is the Chair of the SA/NT Early Career Working Group and a project pharmacist with the Adelaide Respiratory Health Project through Asthma Australia and the Lung Foundation.

 

PSA National President Dr Chris Freeman presented Ms Seda with the Early Career Pharmacist Development Award for raising practice standards and providing a model of practice for her fellow Early Career Pharmacists.

 

“Veronika has a passion for pharmacist communication and is currently a PhD candidate working on a sustainable model for professional services in community pharmacy,” Dr Freeman said.

 

Emeritus Professor Lloyd Sansom AO presented Ms Searle and Ms Ali with the PSA Gold Medal for achieving the highest grade point average in the Bachelor of Pharmacy at the University of South Australia.

 

Ms Searle is a pharmacy intern at Terry White Chemmart Golden Grove and recently started work at Angaston Pharmacy. Ms Ali is currently completing her internship at the Royal Adelaide Hospital.

 

PSA also named pharmacists Dr Jacinta Johnson and Dr Rose Allin Fellows of the Pharmaceutical Society (FPS) for achieving the highest level of Advanced Practice credentialing.

 

Emeritus Professor Andrew Gilbert was awarded PSA Life Fellowship and Mrs Heather Simpson Life Membership for their significant contributions to the profession.

 

Prof Gilbert’s research and consultancy work in medicines policy and health practice change are internationally respected.

 

Mrs Simpson worked at the Kings Park Pharmacy for 30 years, has locumed in rural SA and Western Victoria and dedicates a day a week towards Home Medicines Reviews.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

 

Workshops to help pharmacists make the most of My Health Record

Monday 4 March 2019

 

Pharmacists are invited to participate in a series of free interactive workshops designed to help them get the most out of My Health Record as a tool to support better patient care and health outcomes.

 

9 out of 10 Australians now have a My Health Record and approximately 15,460 healthcare providers are registered to use the system.

 

About 84% of community pharmacies are registered for My Health Record — and the Pharmaceutical Society of Australia and the Australian Digital Health Agency are committed to supporting pharmacists with training as they learn to use the system.

 

PSA National President Dr Chris Freeman said the workshops aligned with one of the key actions identified in PSA’s recent Pharmacists in 2023 report to make full use of pharmacists’ skills and improve the health of all Australians: Embrace digital transformation to improve the quality use of medicines; support the delivery of safe, effective, and efficient healthcare; and facilitate collaborative models of care.

 

“Pharmacists in 2023 states there is a strong need for technological improvement in pharmacist care,” Dr Freeman said.

 

“That’s why we identified technology as a key enabler that will support pharmacists in 2023 to be more responsible and accountable for medicines safety.

 

“These workshops will give pharmacists who are unfamiliar with the system the confidence to use My Health Record — and to communicate more effectively with other health professionals so they can deliver more coordinated care.

 

“At the end of the day, up-skilling pharmacists in the use of My Health Record will deliver better health outcomes and empower consumers through greater access to information.”

 

Pharmacists are invited to attend the Overcoming barriers to My Health Record implementation in pharmacy workshops between March and May 2019 to engage with Digital Health Leaders and explore how to implement and use the My Health Record effectively in their pharmacy.

 

Specialist workshops for accredited pharmacists to explore how to connect with My Health Record and embed it in their regular practice will also be provided.

 

Pharmacists can register online for the Overcoming barriers to My Health Record implementation in pharmacy workshops or the My Health Record for Accredited Pharmacists workshops, or call 1300 369 772 for more information.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

Leadership change at PSA

On Monday 25 February, Graham Catt decided to step down from his role as Chief Executive Officer of PSA. The Board has extended its best wishes to Graham for the future.

 

To ensure a seamless transition and certainty for our members and stakeholders, Dr Shane Jackson has been appointed as interim CEO and Belinda Wood appointed as Deputy CEO. Shane will step down from the PSA Board over this period.

 

The PSA Board thanks Shane for stepping into the role as interim CEO which will continue to see PSA focussed on ensuring that pharmacists are able to practise to full scope, and that they are appropriately remunerated and recognised for their key role in healthcare.

 

We look forward to Pharmacists in 2023 guiding the work of the PSA over the next few years and see that Shane and Belinda will be able to guide this work in the immediate future.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

PSA recognises leadership of retiring Pharmacy Guild Executive Director, David Quilty

Sun 24 February, 2019

 

The Pharmaceutical Society of Australia (PSA) today acknowledges the leadership of David Quilty as he steps down from his role as Executive Director for the Pharmacy Guild of Australia.

 

PSA National President Dr Chris Freeman said PSA had enjoyed a good working relationship with the Pharmacy Guild under David Quilty’s leadership.

 

“On behalf of the PSA Board, CEO and staff, I thank David for his leadership over the past six years,” Dr Freeman said.

 

“David has been a passionate and relentless advocate for community pharmacy and will be remembered for his role in negotiating the Sixth Community Pharmacy Agreement in 2015, and Pharmacy Compact in 2017. We wish David all the very best in his retirement.

 

“PSA looks forward to continuing to engage constructively with the incoming Executive Director on key issues of common interest to progress the roles, recognition and remuneration for pharmacists, so they can provide the best possible care to patients.”

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

 

 

Pharmacists will do more to improve the health of all Australians

February 13, 2019

 

In 2023 pharmacists will be the custodians of medicine safety, embedded wherever medicines are used, and more responsible and accountable for the safe and effective use of medicines, a new report reveals.

 

Pharmacists in 2023: For patients, for our profession, for Australia’s health system, developed by the Pharmaceutical Society of Australia (PSA), reveals the 11 system changes needed for healthcare evolution to deliver safety and quality improvements in the use of medicines, and better use of pharmacists to improve access to healthcare.

 

PSA National President Dr Chris Freeman launched the report today at a breakfast event in Parliament House attended by political leaders and pharmacy experts from across the country.

 

Pharmacists in 2023 is the pharmacy profession’s response to the national medicine safety problem,” Dr Freeman said. “The report unlocks the potential for pharmacists to improve healthcare access and outcomes for Australians and reduce variability in care.”

 

PSA recently showed in its Medicine Safety: Take Care report that 250,000 people are admitted to hospital each year as a result of medicine-related problems, costing the Australian health system $1.4 billion per annum.

 

“Medicine safety should be a national priority. The report identifies the key actions needed to address this issue by unlocking more opportunities for pharmacists as the guardians of medicine safety.

 

“Pharmacists must be empowered to do more than the current system allows them to do. As the only health professionals trained with a specific focus on the effective and safe use of medicines, pharmacists must lead a culture change to embed medicine safety at every point of healthcare delivery.

 

“Rather than gazing into a crystal ball, we have laid out an ambitious agenda for change with tangible and practical actions to support all pharmacists to reach their full potential and provide more effective and efficient healthcare.

 

“All of the actions in Pharmacists in 2023 aim to ensure pharmacists practise to the full extent of their expertise, are recognised for their key role in healthcare and are remunerated appropriately.

 

“Our goal is to ensure any Australian, no matter where they live, can receive the best possible care from a pharmacist, and that pharmacists are supported to address their patients’ needs using the full extent of their training and expertise.”

 

The report is the result of two years of consultation with a wide range of pharmacy, consumer and health stakeholders.

 

For pharmacists in 2023 to address the health needs of all Australians, the report identifies 11 actions for change:

 

  1. Empower and expect all pharmacists to be more responsible and accountable for medicine safety.
  2. Enhance the role of community pharmacists to have a greater level of responsibility and accountability for medicines management.
  3. Embed pharmacists within healthcare teams to improve decision making for the safe and effective use of medicines.
  4. Facilitate pharmacist prescribing within a collaborative care model.
  5. Improve pharmacist stewardship of medicine management to improve outcomes at transitions of care.
  6. Utilise and build upon the accessibility of community pharmacies in primary care to improve consumer access to health services.
  7. Equip the pharmacist workforce, through practitioner development, to address Australia’s existing and emerging health challenges.
  8. Establish additional funding models to recognise the value and quality of pharmacist care.
  9. Allow greater flexibility in funding and delivery of pharmacist care to innovate and adapt to the unique patient needs in regional, rural and remote areas.
  10. Develop and maintain a research culture across the pharmacist profession to ensure a robust evidence base for existing and future pharmacist programs.
  11. Embrace digital transformation to improve the quality use of medicines; support the delivery of safe, effective, and efficient healthcare; and facilitate collaborative models of care.

 

Dr Freeman said, “I now look forward to working with pharmacy leaders, other healthcare groups, consumers and government to advance the role of pharmacists in 2023 – for patients, for our profession and for Australia’s health system.”

 

Read Pharmacists in 2023

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176

Recommendations a major step forward for medicine safety

Thursday 7 February, 2019

 

The recommendation to add pharmacists to the list of eligible allied health professionals to access Medicare Benefits Schedule (MBS) items for medication management services for patients with complex care requirements is an important investment in the safe and effective use of medicines, the Pharmaceutical Society of Australia (PSA) said today.

 

The Allied Health Reference Group of the Medicare Benefits Schedule Review Taskforce has released a consultation document with a recommendation to establish an item to allow pharmacists to provide medication management services to patients with complex care requirements.

 

PSA National President Dr Chris Freeman said this recommendation, along with those made by the General Practice and Primary Care Clinical Committee to remunerate non-doctor health professionals to participate in case conferencing, will go a long way in supporting pharmacists to be better integrated with other healthcare providers in primary care.

 

“We have known for a long time that there are financial and structural impediments to pharmacist involvement in case conferencing, and these recommended changes will help overcome those barriers,” Dr Freeman said.

 

“These recommendations are a major leap forward, empowering pharmacists to practise to the full extent of their expertise and provide the best possible care for their patients.

 

“The recommendations could not be more timely, following on from PSA’s Medicine Safety report that revealed the extent of harms caused by medicines misuse in Australia and highlighted the need for pharmacists to be embedded wherever medicines are used.

 

“PSA has advocated over many years to diversify remuneration to reflect pharmacists’ extensive expertise and contribution to Australia’s health. Pharmacists have been calling for access to the MBS to reflect their skills, training and experience for longer than many of us can remember.

 

“PSA has advocated for pharmacists to be included in the list of eligible allied health practitioners and we have delivered this positive recommendation.

 

“In our 2019-20 Pre-budget submission we urged the Government to add pharmacists to the list of eligible allied health professionals that can deliver MBS services to patients with chronic diseases under the allied health chronic disease management items. We have now made this a reality.

 

“The MBS is a key funding mechanism to support innovative and collaborative models of care for chronic disease and complex conditions. We are delighted that both the Allied Health Reference Group and the General Practice and Primary Care Clinical Committees have listened to PSA and recommended allowing pharmacists to access these MBS items.

 

“Pharmacists should be able to deliver these services from any setting, including general practice, aboriginal health services and community pharmacies. This is about the right pharmacist, with the right skill set at the right time working as part of a multidisciplinary collaborative team.

 

“This is an innovative and cost-effective solution to address challenges in the health system and reduce harm caused by medicines.”

 

PSA’s Pre-budget submission also called for continued funding for integrating pharmacists in Aboriginal Community Controlled Health Services to improve chronic disease management.

 

In line with PSA’s recommendation, the Reference Group has recommended building and investing in an allied health research base to support evidence-based strategies for integrated or collaborative approaches to chronic disease management.

 

“This will help address health inequalities for Aboriginal and Torres Strait Islander peoples and rural and remote communities,” Dr Freeman said.

 

“We are excited that our advocacy is unlocking opportunities for pharmacists to realise their full potential. We look forward to working with the committees involved in the Medicare Benefits Schedule Review as they undertake their consultation on these recommendations, and finally when they will be presented to the Minister for Health.

 

“We also look forward to the Minister for Health making these recommendations a reality after the consultation process has been finalised to ensure pharmacists can do more with medicines for more Australians.”

 

Media contact: 
Jarryd Luke
Senior Communications Officer 
0487 922 176

Medicine safety should be a priority in 2019-20 Federal Budget

Wednesday 6 February 2019

 

Innovative and cost-effective solutions to current health system challenges, including harm caused by medicine misuse, have been recommended by the Pharmaceutical Society of Australia (PSA) in its 2019-20 Federal Budget submission.

 

PSA National President Dr Chris Freeman said PSA’s Medicine Safety: Take Care report, released last week, showed medicine safety was a major problem in Australia.

 

“PSA’s Medicine Safety report reveals that 250,000 people go to hospital each year because of medicine misuse, costing the health system $1.4 billion annually,” Dr Freeman said.

 

“Every day, pharmacists are faced with situations where the health system fails to meet their patients’ needs. Pharmacists want to use their knowledge to provide more effective care.

 

“The public considers pharmacists approachable, knowledgeable and highly trusted. People value pharmacists’ expertise and want to see it put to full use.

 

“However, structural and funding barriers are holding pharmacists back from participating in key Government initiatives. As the peak national body for pharmacists, PSA has made cost-effective recommendations for removing these obstacles and maximising the safe use of medicines.”

 

PSA recommends the 2019-20 Federal Budget makes provision to:

 

  • Provide seed funding to embed pharmacists in residential aged care facilities to improve the Quality Use of Medicines and in particular to reduce harm caused by overuse of psychotropic medicines, opioids and antibiotics
  • Grow the extensive immunisation network in primary care to boost vaccination rates
  • Facilitate the appointment of a Commonwealth Chief Pharmacist to improve the Commonwealth Government’s coordination and responsiveness to medication issues in Australia’s complex healthcare system
  • Establish funding mechanisms to facilitate collaborative practice between Aboriginal Health Services and community pharmacies
  • Add pharmacists to the list of eligible allied health professionals that can deliver MBS services to patients with chronic diseases under the allied health chronic disease management items.

 

These recommendations aim to enhance the Government’s existing health investments and do not duplicate or inhibit any initiatives in the 6th Community Pharmacy Agreement.

 

“The 2019-20 Federal Budget is an opportunity to enhance the use of pharmacists’ skills and expertise for the betterment of Australia’s health,” Dr Freeman said. “We urge the Government to partner with pharmacists to unlock this opportunity by funding the initiatives in PSA’s submission.”

 

Media contact:

Jarryd Luke
Senior Communications Officer
0487 922 176

Alyssa Murray wins Pharmacy Student of the Year Wildcard

Sunday January 27, 2019

 

Alyssa Murray from Queensland has won the National Australian Pharmacy Students’ Association (NAPSA) Wildcard for the 2019 PSA Pharmacy Student of the Year (PSOTY) Award.

 

PSA National President Dr Chris Freeman announced the award at the NAPSA Congress Gala Ball in Adelaide tonight.

 

Dr Freeman congratulated Ms Murray on her exceptional achievement.

 

“Ms Murray and all of the finalists demonstrated exceptional counselling skills and impressive pharmacy knowledge,” Dr Freeman said.

 

“It was great to see so much talent on display at the competition today.

 

“Seeing these rising stars in action fills me with confidence about the future of the profession.”

 

Ms Murray is completing a Bachelor of Pharmacy at the University of Queensland and is a member of the Queensland Pharmacy Students Association (QPSA).

 

The judges were impressed by the strong field of finalists:

 

  • Noor Shoaib, La Trobe University (VIC)
  • Vivien Banks, University of Queensland (QLD)
  • Jacqui Leggett, Queensland University of Technology (QLD)
  • Stephanie Samios, University of Queensland (QLD)
  • Sean Richardson, University of South Australia (SA)

 

The award is proudly sponsored by Mylan.

 

Ms Murray will now travel to PSA’s national conference PSA19 from 26 to 28 July 2019 in Sydney to compete in the prestigious national final.

 

“PSA thanks Mylan for their fantastic support of this award,” Dr Freeman said.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176
media@psa.org.au

Pharmacists recognised in Australia Day Honours

Saturday January 26, 2019

 

Respected pharmacists and PSA members Grant Kardachi FPS, Dr Geraldine Moses FPS, Emil Dan FPS, Dr Carol Armour FPS and Dr Ross Holland FPS have been congratulated by the Pharmaceutical Society of Australia (PSA) for being awarded the status of Member of the Order of Australia (AM).

 

PSA also applauds PSA members Geoffrey Pritchard FPS, Leonard Levy MPS and Robert Kalaf MPS for receiving the Medal of the Order of Australia (OAM).

 

Pharmacists Jim Siderov, Paul Sinclair and Bakhos Georges were also honoured with the Member of the Order of Australia during the Australia Day celebrations last night.

 

PSA National President Dr Chris Freeman congratulated all of the pharmacists who were recognised.

 

“I applaud all of the exceptional pharmacists for their tireless dedication to their profession, to their community’s health and to their peak national body, PSA,” Dr Freeman said.

 

“The pharmacy profession has been well represented in this year’s awards. It’s inspiring to see so many pharmacists honoured for their pioneering work to improve Australia’s health.

 

“These respected leaders and role models have set an inspiring example for our profession.”

 

Mr Kardachi from Unley Park in South Australia is a past National President and current National Board Director of PSA. Mr Kardachi has owned several community pharmacies while supporting research projects in medication management. He has served the state of South Australia through various foundations, boards and committees.

 

From Corinda in Queensland, Dr Moses is a hospital-based drug information consultant and clinical pharmacist. She provides the Australian Dental Association’s national drug information advisory service Pharma-Advice. Dr Moses is an adjunct associate professor at the University of Queensland and co-founder of medicines education service Pharmeducation. She has served as a member of the PSA Queensland Branch Committee and received PSA’s prestigious Bowl of Hygeia Award in 1993.

 

Mr Dan from Marourbra in NSW received a PSA Lifetime Award of Excellence in 2009 and has since become a PSA Life Fellow. He was an early pioneer of asthma research in Australia, founding the anti-allergy and asthma treatment initiative Allersearch. His groundbreakng work in this area also includes research for smoking cessation services in pharmacy at the Woolcock Institute of Respiratory Medicine, and lecturing for PSA and the Asthma Foundation.

 

Dr Armour is a Professor of Pharmacy and Associate Dean of Career Development, Sydney Medical School at the University of Sydney. She was recognised for significant service to medical education and asthma management.

 

Dr Holland was recognised for significant service to pharmacy practice, medical education and professional organisations. Hailing from NSW, he is a PSA Life Fellow and has served as the Dean of Academic Studies at the Australian College of Pharmacy Practice. He is a Past Faculty Member of the World Health Organisation Regional Teacher Training Centre, South Korean Clinical Pharmacy Association.

 

Recognised for his service to the pharmacy profession, Mr Pritchard from Milsons Point in NSW is a PSA Life Fellow and served as a Liaison Officer for the PSA NSW Branch. His contributions include Director of Pharmacy Services at the Sydney Olympic Games and a number of roles at the Pharmacy Council of New South Wales.

 

Mr Levy from North Caulfield in Victoria has made longstanding contributions to the Victorian Branch of PSA, including as a Councillor and Chair of various committees. He has contributed many years of service to the Pharmacy Board of Victoria.

 

Mr Kalaf has worked as a pharmacist at Cooranbong Pharmacy and Compounding in NSW for more than 25 years. His community service roles include President of the Cooranbong Chamber of Commerce, Member of the Sewerage Development Committee and Member of the Tidy Towns Committee.

 

Media contact:
Jarryd Luke
Senior Communications Officer
0487 922 176